How Precision Diagnostics is Driving the EPO Biomarkers Market Growth
The global Erythropoietin (EPO) Biomarkers Market is gaining significant traction as healthcare systems increasingly prioritize early diagnosis and precision-based monitoring of hematological and renal disorders. According to Polaris Market Research, the market was valued at USD 665.41 million in 2025 and is projected to reach USD 1,433.15 million by 2034, expanding at a steady CAGR of 8.90%...
0 Commenti 0 condivisioni 78 Views 0 Anteprima